Home
Search
BIO Digital

Speakers & Presenters

Meet the experts speaking on our world-class education program.

June 8-12, 2020
Register
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies

2020 BIO Digital Education Program

New speakers and presenters confirmed regularly, so check back frequently for updates.

Featured Speakers
Dr. Fauci
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
ANTHONY S. FAUCI, MD is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health,…
Paul Stoffels
Paul Stoffels, MD
VICE CHAIRMAN OF THE EXECUTIVE COMMITTEE AND CHIEF SCIENTIFIC OFFICER, JOHNSON & JOHNSON
Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of…
Sharon Chan
Sharon Chan, MBA, MPH, D. Phil
HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON INNOVATION
Sharon Chan is the Head of JLABS @ Shanghai. In this role, Sharon is responsible for setting the strategic direction and overseeing all operational…
Dr. Fauci
Paul Stoffels
Sharon Chan
All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Company Type
Main Therapeutic Focus
Development Phase of Primary Product
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Federico Mingozzi, PhD
CHIEF SCIENTIFIC OFFICER, SPARK THERAPEUTICS
The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond
photo
Sandy Macrae, PhD
CEO, SANGAMO THERAPEUTICS
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
San Francisco, California, United States
photo
Marinna Madrid
CO-FOUNDER, CELLINO
Cellino
Cambridge, Massachusetts, United States
photo
Stanley Maloy, PhD
ASSOCIATE VICE PRESIDENT FOR INNOVATION, SAN DIEGO STATE UNIVERSITY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
photo
Doug Manion, MD
CEO, KLEO PHARMACEUTICALS, INC.
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
New Haven, Connecticut, United States
photo
Husseini Manji, MD, FRCP (C)
GLOBAL THERAPEUTIC AREA HEAD, NEUROSCIENCE, JOHNSON & JOHNSON
How COVID-19 Has Impacted the Global Psyche
Titusville, New Jersey, United States
photo
Upendra Marathi
PRESIDENT & CEO, 7 HILLS PHARMA
7 Hills Pharma
Houston, Texas, United States
photo
Heidi Marchand, PharmD, RPh
GLOBAL HEAD, REGULATORY POLICY AND INTELLIGENCE, GILEAD SCIENCES
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
photo
Gary Margolis
CEO, NOTOGEN, INC.
Notogen, Inc.
Toronto, Ontario, Canada
photo
Brad Margus
CHIEF EXECUTIVE OFFICER, CEREVANCE
Battle of the Brains: Rethinking Neurodegenerative Disease Treatment
Boston, Massachusetts, United States
photo
John Markels
PRESIDENT, MERCK VACCINES, MERCK & CO.
A Way Forward: Winning the War on COVID through Vaccines
North Wales, Pennsylvania, United States
Peter Marks
Peter Marks, MD, PhD
DIRECTOR, CENTERS FOR BIOLOGICS EVALUATION & RESEARCH, US FOOD & DRUG ADMINISTRATION
A Way Forward: Winning the War on COVID through Vaccines
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
FDA Town Hall
Silver Spring, Maryland, United States
photo
Andy Marshall, PhD
CHIEF EDITOR, NATURE BIOTECHNOLOGY
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
photo
Brian Martin, BS, MS
HEAD OF AI IN R&D INFORMATION RESEARCH, SENIOR PRINCIPAL DATA SCIENTIST, ABBVIE
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
Lake Forest, Illinois, United States
photo
Linda Masat
V.P. BUSINESS DEVELOPMENT, TRIANNI INC.
Trianni, Inc
San Francisco, CA, California, United States
photo
Neal Masia, PhD
CEO, HEALTH CAPITAL GROUP
Financing Transformative Therapies: Cross-sector perspective on value and payment
New York, New York, United States
photo
Cristina Masseria, MSc, PhD
VP PATIENT HEALTH & IMPACT, VACCINES, PFIZER
Financing Transformative Therapies: Cross-sector perspective on value and payment
photo
Gary Mathias
CEO, THETIS PHARMACEUTICALS
Thetis Pharmaceuticals
Branford, Connecticut, United States
photo
Kazuhiro Matsuda
PRESIDENT, M BIO TECHNOLOGY INC.
M Bio Technology Inc.
Tokyo, Japan
photo
Osamu Matsuzaki
BOARD DIRECTOR, SENIOR EXECUTIVE OFFICER, HEAD OF R&D AND BD, ASAHI KASEI PHARMA CORPORATION
Asahi Kasei Pharma Corporation
Tokyo, Japan
photo
Martin Matthews
DIRECTOR OF GOVERNMENT AFFAIRS, MERCK & CO.
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
North Wales, Pennsylvania, United States
photo
Allison Matusick
GLOBAL ACCOUNTS DIRECTOR, CORNING INCORPORATED
Corning Incorporated
Corning, New York, United States
photo
Jeff May
VICE PRESIDENT, GLOBAL PUBLIC POLICY, MERCK
International Trade in the Times of COVID-19
Kenilworth, New Jersey, United States
photo
Kiran Mazumdar Shaw
CHAIRPERSON & MANAGING DIRECTOR, BIOCON LIMITED
The Lure of Universal Healthcare ! What India is doing in Healthcare
Bangalore, India
photo
James McArthur, D. Phil, BSc
FOUNDER & PRESIDENT, R&D, CYDAN
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Cambridge, Massachusetts, United States
photo
Andrew McCandlish
HEAD OF US BUSINESS DEVELOPMENT, PH PHARMA
Getting a seat at the table: how can new small companies enter the oncology space?
South San Francisco, California, United States
photo
Reenie McCarthy
CHIEF EXECUTIVE OFFICER, STEALTH BIOTHERAPEUTICS
Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation
Newtown, Massachusetts, United States
photo
Barbara McClung
CHIEF LEGAL OFFICER AND CORPORATE SECRETARY, CARIBOU BIOSCIENCES, INC.
GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes
GETTING TO YES: Negotiating IP Terms in Contracts
Berkeley, California, United States
photo
Joshua McClure, MBA
CEO, MAXWELL BIOSCIENCES
MaxWell Biosciences
Austin , Texas, United States
photo
Mark McCord-Amasis, MBA, MSc
VICE PRESIDENT, REAL ESTATE & FACILITIES, SEATTLE GENETICS
Identify and Mitigate: “Bet Your Company” Risks
BOTHELL, Washington, United States
photo
Andrew McKee, MD
CEO AND PRESIDENT, HEADLAND STRATEGY GROUP
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
San Francisco, California, United States
photo
Matt McLoughlin
VP OF COMPLIANCE & CATEGORIES, SCIENTIST.COM
Scientist.com
London, California, United Kingdom
photo
Matthew McMahon
FEDERAL PROGRAM STAFF, NIH SEED
The Key Role of NIH in the Product Development Pipeline
photo
Gianna McMillan
, BIOETHICS INSTITUTE AT LOYOLA MARYMOUNT UNIVERSITY
Including the Patient Voice to Advance Diversity and Support Clear Communications
Michelle McMurry-Heath
Michelle McMurry-Heath, MD, PhD
INCOMING PRESIDENT AND CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
Science on the Front Lines & on the Front Page
A Way Forward: Winning the War on COVID through Vaccines
Fireside Chat with Jim Greenwood and Michelle McMurry-Heath, BIO
Washington, United States
photo
Jenn McNary
PATIENT ADVOCATE, J. MCNARY CONSULTING
Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage
Boston, Massachusetts, United States
photo
David Mead, PhD
CEO, VARIGEN BIOSCIENCES
Varigen Biosciences
Madison, Wisconsin, United States
photo
Ravi Mehrota, PhD
, 5POINT0
Patents in the Time of Covid-19: Innovation and Access to Medicine now and for the future
photo
Joseph (Joe) Melnik
PARTNER, JONES DAY
GETTING TO YES: Negotiating IP Terms in Contracts
Palo Alto, California, United States
photo
Philipp Mews
COFOUNDER , EPIVARIO INC.
PTSD treatment limitations and novel pharmacotherapy approaches to transform standard of care
New York, New York, United States
photo
Annastasiah Mudiwa Mhaka, PhD
CO-FOUNDER, CONVENOR, FORMER PRESIDENT; FOUNDER, ALLIANCE FOR ARTIFICIAL INTELLIGENCE IN HEALTHCARE; MAWAMBO LIFESCIENCES
Can AI Prevent Epidemics?
photo
Zhuqi Miao
INTERIM MANAGER, INSTITUTE OF PREDICTIVE MEDICINE , OKLAHOMA STATE UNIVERSITY—CENTER FOR HEALTH SYSTEMS INNOVATION (CHSI)
Oklahoma State University—Center for Health Systems Innovation (CHSI)
Stillwater, Oklahoma, United States
photo
Michael Miller, PhD
CEO, PROTERIXBIO
Digital Health in Respiratory Care – The Next Frontier
Billerica, Massachusetts, United States
photo
Debra Miller
CHIEF EXECUTIVE OFFICER & FOUNDER, CUREDUCHENNE
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Newport Beach, California, United States
photo
Jennifer Miller, PhD
ASSISTANT PROFESSOR, FOUNDER, YALE SCHOOL OF MEDICINE, BIOETHICS INTERNATIONAL
Genomic medicine and bioethics – Ushering in a new era of responsible healthcare
photo
Steve Miller, MD
EVP & CHIEF CLINICAL OFFICER, CIGNA CORPORATION
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Financing Transformative Therapies: Cross-sector perspective on value and payment
Missouri, United States
photo
Emily Milligan
Mitochondria: How the Relic from Biology Class Could be the Next Powerhouse for Biopharmaceutical Innovation
photo
Elizabeth Mily
EXECUTIVE VICE PRESIDENT, STRATEGY & BUSINESS DEVELOPMENT , BRISTOL MYERS SQUIBB
How to Get Acquired: What Companies Look for When in Acquisition Mode
Bristol Myers Squibb
Princeton , New Jersey, United States
photo
Frank Minella
FOUNDER & CEO, PAINQX
PainQx
Philadelphia, Pennsylvania, United States
photo
Brigitta Miranda-Freer
EXECUTIVE DIRECTOR, MONTANA WORLD TRADE CENTER
Montana - Global Innovation Hub
Missoula, Montana, United States
photo
Tim Mitchell
CEO, SAREUM
Sareum Holdings plc
Cambridge, United Kingdom
photo
Kenneth Moch
SERIAL BIOTECH EXECUTIVE AND FORMER CEO, COGNITION THERAPEUTICS AND CHIMERIX
Bioethics Through the Lens of a Pandemic
photo
James Moe
PRESIDENT AND CEO , OLIGOMERIX, INC.
Oligomerix, Inc.
Bronx, New York, United States
photo
Amanda Moore
CEO , ANGELMAN SYNDROME FOUNDATION
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Indianapolis, Indiana, United States
photo
K. Scott Moorefield
CHIEF BUSINESS OFFICER, BOUNDLESS BIO INC.
Boundless Bio Inc.
La Jolla , California, United States
photo
Susan Moran, MD, MSc
CHIEF MEDICAL OFFICER, QED THERAPEUTICS / BRIDGEBIO
Looking for the Next Targeted Oncology Blockbuster
San Francisco, California, United States
photo
Ross Muken
CFO, CLICK THERAPEUTICS
Click Therapeutics
New York, New York, United States
photo
Ryan Muldoon
CEO, PREP BIOPHARM
PrEP Biopharm
London, United Kingdom
photo
Theresa Mulloy, BA
PROGRAM MANAGER INTERNATIONAL BUSINESS PROMOTION & INWARD INVESTMENT, PUGLIA SVILUPPO S.P.A.
Puglia Sviluppo S.p.A.
Modugno, Italy
photo
Carolyn Mulroney
HEMATOLOGIST/MEDICAL ONCOLOGIST, ASSOCIATE PROFESSOR OF MEDICINE, UC SAN DIEGO HEALTH, UNIVERSITY OF CALIFORNIA SAN DIEGO
Transplant 2.0: Driving Forward Innovation for Patients with Blood Cancer
La Jolla, CA, California, United States
photo
Anant Murthy, PhD
VICE PRESIDENT PRICING, MARKET ACCESS & POLICY, EUROPA/CANADA/MEA; GENERAL MANAGER, CANADA, BENELUX, NORDICS AND PORTUGAL, ALNYLAM PHARMACEUTICALS, INC.
“Start Me Up”: How Can Europe’s Biotech Sector Combat the Coronavirus?
Cambridge, Massachusetts, United States
photo
Nikolai Muth
PROJECT COORDINATOR, CITY OF YOKOHAMA REP. TO THE AMERICAS
City of Yokohama Rep. to the Americas
New York, New York, United States
Load More